Commentary on prevention a possible drug-drug interaction: is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity?

International Journal of Preventive Medicine
Marjan EmzhikAshraf Sadat Moazzam

Abstract

Drug-drug interactions (DDIs) are an emerging threat to public health and are difficult to detect. To prevent DDIs and their burden, the possible DDIs should be kept in mind. We know that the obesity predisposes to the development of insulin resistance and type 2 diabetes. Therefore, combinational uses of antiobesity drugs and glucose-lowering drugs are very common. As the hepatotoxicity of both pioglitazone (an antidiabetic drug) and orlistat (an antiobesity drug) has been shown in some cases, the aim of this study was to evaluate the interaction of pioglitazone and orlistat in human hepatocellular cell line human hepatocellular carcinoma (HepG2) cells to determine their effect on liver toxicity. Human hepatocellular carcinoma cells were treated with 25 μM Pioglitazon (Pio), 20 μM Orlistat (Orl) pioglitazone, orlistat or combination of them. The MTT assay was used to assess cell viability. Pioglitazone and orlistat combination caused a loss of HepG2 cell viability. While pioglitazone (25 μM) and orliatat (20 μM) alone decreased the cell viability around 91% and 85% respectively (notsignificant, P > 0.05), the combination of these two drugs reduced the amount of viable cells to 55% which was significant when compared with each ...Continue Reading

Citations

Jun 13, 2015·Biological Research·Mohamed M HafezOthman A Al-Shabanah
Jan 15, 2017·BMC Complementary and Alternative Medicine·Mohamed M HafezShakir Dekhal Alsharari

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
O J PhungC I Coleman
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research
Elvira O GosmanovaBarry M Wall
The Annals of Pharmacotherapy
Laura J Snider, Margaret Malone
© 2021 Meta ULC. All rights reserved